Kraeber-Bodéré, F.; Rousseau, C.; Bodet-Milin, C.; Mathieu, C.; Guérard, F.; Frampas, E.; Carlier, T.; Chouin, N.; Haddad, F.; Chatal, J.-F.;
et al. Tumor Immunotargeting Using Innovative Radionuclides. Int. J. Mol. Sci. 2015, 16, 3932-3954.
https://doi.org/10.3390/ijms16023932
AMA Style
Kraeber-Bodéré F, Rousseau C, Bodet-Milin C, Mathieu C, Guérard F, Frampas E, Carlier T, Chouin N, Haddad F, Chatal J-F,
et al. Tumor Immunotargeting Using Innovative Radionuclides. International Journal of Molecular Sciences. 2015; 16(2):3932-3954.
https://doi.org/10.3390/ijms16023932
Chicago/Turabian Style
Kraeber-Bodéré, Françoise, Caroline Rousseau, Caroline Bodet-Milin, Cédric Mathieu, François Guérard, Eric Frampas, Thomas Carlier, Nicolas Chouin, Ferid Haddad, Jean-François Chatal,
and et al. 2015. "Tumor Immunotargeting Using Innovative Radionuclides" International Journal of Molecular Sciences 16, no. 2: 3932-3954.
https://doi.org/10.3390/ijms16023932
APA Style
Kraeber-Bodéré, F., Rousseau, C., Bodet-Milin, C., Mathieu, C., Guérard, F., Frampas, E., Carlier, T., Chouin, N., Haddad, F., Chatal, J.-F., Faivre-Chauvet, A., Chérel, M., & Barbet, J.
(2015). Tumor Immunotargeting Using Innovative Radionuclides. International Journal of Molecular Sciences, 16(2), 3932-3954.
https://doi.org/10.3390/ijms16023932